Citadel Advisors - HILLSTREAM BIOPHARMA INC ownership

HILLSTREAM BIOPHARMA INC's ticker is and the CUSIP is 432705101. A total of 9 filers reported holding HILLSTREAM BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of HILLSTREAM BIOPHARMA INC
ValueSharesWeighting
Q4 2022$4,706
-86.9%
12,252
-72.2%
0.00%
Q3 2022$36,000
-7.7%
44,065
+81.9%
0.00%
Q1 2022$39,00024,2220.00%
Other shareholders
HILLSTREAM BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Murchinson Ltd. 116,029$186,0000.04%
K.J. Harrison & Partners Inc 23,400$37,0000.01%
JANE STREET GROUP, LLC 23,825$38,0000.00%
WELLS FARGO & COMPANY/MN 23$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 126$00.00%
BlackRock Inc. 9,622$15,0000.00%
Citadel Advisors 24,222$39,0000.00%
Tower Research Capital LLC (TRC) 8,111$13,0000.00%
View complete list of HILLSTREAM BIOPHARMA INC shareholders